Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENTILULA: [177Lu]Lu-PentixaTher in Relapsed/Refractory Acute Leukemia
NCT06356922Phase 2Active, not recruiting
- Sponsor
- CHU de Nantes
- Start
- Oct 2024
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lu177-pentixather in acute leukemia, sponsored by CHU de Nantes. Started Oct 2024; status: active, not recruiting.
02
Drugs
Lu177-pentixather
03
Conditions
acute leukemia
Beyond the preview
Go deeper on NCT06356922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06356922.